Correlation Between Mereo BioPharma and Weiss Korea

Can any of the company-specific risk be diversified away by investing in both Mereo BioPharma and Weiss Korea at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mereo BioPharma and Weiss Korea into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Mereo BioPharma Group and Weiss Korea Opportunity, you can compare the effects of market volatilities on Mereo BioPharma and Weiss Korea and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mereo BioPharma with a short position of Weiss Korea. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mereo BioPharma and Weiss Korea.

Diversification Opportunities for Mereo BioPharma and Weiss Korea

0.7

Correlation Coefficient

Mereo BioPharma  Weiss Korea

Poor diversification

The 3 months correlation between Mereo and Weiss is 0.7. Overlapping area represents the amount of risk that can be diversified away by holding Mereo BioPharma Group and Weiss Korea Opportunity in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Weiss Korea Opportunity and Mereo BioPharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mereo BioPharma Group are associated (or correlated) with Weiss Korea. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Weiss Korea Opportunity has no effect on the direction of Mereo BioPharma i.e., Mereo BioPharma and Weiss Korea go up and down completely randomly.

Pair Corralation between Mereo BioPharma and Weiss Korea

Assuming the 90 days trading horizon Mereo BioPharma is expected to generate 7.98 times less return on investment than Weiss Korea. In addition to that, Mereo BioPharma is 1.39 times more volatile than Weiss Korea Opportunity. It trades about 0.02 of its total potential returns per unit of risk. Weiss Korea Opportunity is currently generating about 0.2 per unit of volatility. If you would invest  13,700  in Weiss Korea Opportunity on October 6, 2024 and sell it today you would earn a total of  2,049  from holding Weiss Korea Opportunity or generate 14.96% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	95.0%
Values	Daily Returns

Mereo BioPharma Group  vs.  Weiss Korea Opportunity

Mereo BioPharma Group

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Mereo BioPharma Group has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in February 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Weiss Korea Opportunity

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Weiss Korea Opportunity has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Weiss Korea is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

Pair Trading with Mereo BioPharma and Weiss Korea

The main advantage of trading using opposite Mereo BioPharma and Weiss Korea positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mereo BioPharma position performs unexpectedly, Weiss Korea can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Weiss Korea will offset losses from the drop in Weiss Korea's long position.

The idea behind Mereo BioPharma Group and Weiss Korea Opportunity pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.